Literature DB >> 30355116

Astrocyte-Derived Exosomes Treated With a Semaphorin 3A Inhibitor Enhance Stroke Recovery via Prostaglandin D2 Synthase.

Kenichiro Hira1, Yuji Ueno1, Ryota Tanaka1,2,3, Nobukazu Miyamoto1, Kazuo Yamashiro1, Toshiki Inaba4, Takao Urabe4, Hideyuki Okano5, Nobutaka Hattori1.   

Abstract

Background and Purpose- Exosomes play a pivotal role in neurogenesis. In the peri-infarct area after stroke, axons begin to regenerate but are inhibited by astrocyte scar formation. The direct effect and underlying molecular mechanisms of astrocyte-derived exosomes on axonal outgrowth after ischemia are not known. Methods- Using a semaphorin 3A (Sema3A) inhibitor, we explored neuronal signaling during axonal outgrowth after ischemia in rats subjected to middle cerebral artery occlusion and in cultured cortical neurons challenged with oxygen-glucose deprivation. Furthermore, we assessed whether this inhibitor suppressed astrocyte activation and regulated astrocyte-derived exosomes to enhance axonal outgrowth after ischemia. Results- In rats subjected to middle cerebral artery occlusion, we administered a Sema3A inhibitor into the peri-infarct area from 7 to 21 days after occlusion. We found that phosphorylated high-molecular weight neurofilament-immunoreactive axons were increased, glial fibrillary acidic protein-immunoreactive astrocytes were decreased, and functional recovery was promoted at 28 days after middle cerebral artery occlusion. In cultured neurons, the Sema3A inhibitor decreased Rho family GTPase 1, increased R-Ras, which phosphorylates Akt and glycogen synthase kinase 3β (GSK-3β), selectively increased phosphorylated GSK-3β in axons, and thereby enhanced phosphorylated high-molecular weight neurofilament-immunoreactive axons after oxygen-glucose deprivation. In cultured astrocytes, the Sema3A inhibitor suppressed activation of astrocytes induced by oxygen-glucose deprivation. Exosomes secreted from ischemic astrocytes treated with the Sema3A inhibitor further promoted axonal elongation and increased prostaglandin D2 synthase expression on microarray analysis. GSK-3β+ and prostaglandin D2 synthase+ neurons were robustly increased after treatment with the Sema3A inhibitor in the peri-infarct area. Conclusions- Neuronal Rho family GTPase 1/R-Ras/Akt/GSK-3β signaling, axonal GSK-3β expression, and astrocyte-derived exosomes with prostaglandin D2 synthase expression contribute to axonal outgrowth and functional recovery after stroke.

Entities:  

Keywords:  astrocytes; axon; exosomes; neurons; semaphorin 3A; stroke

Mesh:

Substances:

Year:  2018        PMID: 30355116     DOI: 10.1161/STROKEAHA.118.021272

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  28 in total

Review 1.  Crosstalk of Astrocytes and Other Cells during Ischemic Stroke.

Authors:  Tingting He; Guo-Yuan Yang; Zhijun Zhang
Journal:  Life (Basel)       Date:  2022-06-17

Review 2.  Astrocyte-derived extracellular vesicles: Neuroreparative properties and role in the pathogenesis of neurodegenerative disorders.

Authors:  Raghavendra Upadhya; Winston Zingg; Siddhant Shetty; Ashok K Shetty
Journal:  J Control Release       Date:  2020-04-11       Impact factor: 9.776

3.  Astrocyte-derived extracellular vesicles enhance the survival and electrophysiological function of human cortical neurons in vitro.

Authors:  Changho Chun; Alec S T Smith; Hyejin Kim; Dana S Kamenz; Jung Hyun Lee; Jong Bum Lee; David L Mack; Mark Bothwell; Claire D Clelland; Deok-Ho Kim
Journal:  Biomaterials       Date:  2021-02-03       Impact factor: 12.479

Review 4.  Extracellular Vesicle Application as a Novel Therapeutic Strategy for Ischemic Stroke.

Authors:  Yiyang Li; Bowen Liu; Ying Chen; Xingping Quan; Yan Han; Ying Zheng; Yonghua Zhao
Journal:  Transl Stroke Res       Date:  2021-05-13       Impact factor: 6.829

5.  Improved post-stroke spontaneous recovery by astrocytic extracellular vesicles.

Authors:  Yessica Heras-Romero; Axayacatl Morales-Guadarrama; Ricardo Santana-Martínez; Isaac Ponce; Ruth Rincón-Heredia; Augusto César Poot-Hernández; Araceli Martínez-Moreno; Esteban Urrieta; Berenice N Bernal-Vicente; Aura N Campero-Romero; Perla Moreno-Castilla; Nigel H Greig; Martha L Escobar; Luis Concha; Luis B Tovar-Y-Romo
Journal:  Mol Ther       Date:  2021-09-24       Impact factor: 11.454

Review 6.  Extracellular vesicles in neuroinflammation: Pathogenesis, diagnosis, and therapy.

Authors:  Jing Ruan; Xiaomin Miao; Dirk Schlüter; Li Lin; Xu Wang
Journal:  Mol Ther       Date:  2021-04-23       Impact factor: 12.910

Review 7.  The Emerging Role of Extracellular Vesicle Derived From Neurons/Neurogliocytes in Central Nervous System Diseases: Novel Insights Into Ischemic Stroke.

Authors:  Fan Li; Xiaokui Kang; Wenqiang Xin; Xin Li
Journal:  Front Pharmacol       Date:  2022-04-26       Impact factor: 5.988

8.  LncRNA MEG3 targeting miR-424-5p via MAPK signaling pathway mediates neuronal apoptosis in ischemic stroke.

Authors:  Yanxiao Xiang; Yayun Zhang; Yanni Xia; Hua Zhao; Anchang Liu; Yuguo Chen
Journal:  Aging (Albany NY)       Date:  2020-02-16       Impact factor: 5.682

9.  Direct myosin-2 inhibition enhances cerebral perfusion resulting in functional improvement after ischemic stroke.

Authors:  Máté Pénzes; Demeter Túrós; Domokos Máthé; Krisztián Szigeti; Nikolett Hegedűs; Anna Ágnes Rauscher; Péter Tóth; Ivan Ivic; Parasuraman Padmanabhan; Gabriella Pál; Árpád Dobolyi; Máté Gyimesi; András Málnási-Csizmadia
Journal:  Theranostics       Date:  2020-04-06       Impact factor: 11.556

Review 10.  From Tumor Metastasis towards Cerebral Ischemia-Extracellular Vesicles as a General Concept of Intercellular Communication Processes.

Authors:  Xuan Zheng; Mathias Bähr; Thorsten R Doeppner
Journal:  Int J Mol Sci       Date:  2019-11-28       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.